Stericycle (Stericycle) Interest Expense

: $-74 Mil (TTM As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Stericycle's interest expense for the three months ended in Dec. 2023 was $ -17 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-74 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Stericycle's Operating Income for the three months ended in Dec. 2023 was $ 37 Mil. Stericycle's Interest Expense for the three months ended in Dec. 2023 was $ -17 Mil. Stericycle's Interest Coverage for the quarter that ended in Dec. 2023 was 2.18. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Stericycle Interest Expense Historical Data

The historical data trend for Stericycle's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stericycle Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-118.30

-81.90

-71.90

-75.50

-73.90

Stericycle Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-20.90	-20.40	-19.10	-17.40	-17.00

Stericycle Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-74 Mil.

Stericycle (NAS:SRCL) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Stericycle's Interest Expense for the three months ended in Dec. 2023 was $-17 Mil. Its Operating Income for the three months ended in Dec. 2023 was $37 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $1,657 Mil.

Stericycle's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	37.1	/	-17
	=	2.18

The higher the ratio, the stronger the company's financial strength is.

Stericycle (Stericycle) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Waste Management » Stericycle Inc (NAS:SRCL) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

SY9:Germany

Address

2355 Waukegan Road, Bannockburn, IL, USA, 60015

Website

https://www.stericycle.com

Stericycle is the largest provider of medical waste disposal and data destruction (primarily paper shredding) services in the United States. Its next closest national competitor in the medical waste disposal space is Sharps Compliance, which generated $76 million of sales in fiscal 2021 before its 2022 acquisition (about 4% of Stericycle's global regulated waste and compliance revenue). Stericycle's data destruction business (Shred-It) is about twice the size of its closest competitor (Iron Mountain's information destruction segment). Stericycle has a global presence, with about 20% of its revenue earned outside North America.

Executives

Joseph Anthony Reuter	officer: EVP & Chief People Officer	2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
Victoria L Dolan	director	C/O COLGATE-PALMOLIVE COMPANY, 300 PARK AVENUE, NEW YORK NY 10022
Naren K Gursahaney	director	1501 YAMATO ROAD, BOCA RATON FL 33431
White Stephen Cory	officer: EVP C&RS	2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
Daniel Ginnetti	officer: Chief Financial Officer	2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
David W. Stahl	officer: EVP and CIO	2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
James L Welch	director	5550 SW MACADAM AVENUE, SUITE 200, PORTLAND OR 97239
James J Martell	director	314 RINGLING POINT DRIVE, SARASOTA FL 34234
Janet Zelenka	officer: EVP, Chief Financial Officer	2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
Dominic Culotta	officer: EVP Engineering	2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
Mark C Miller	officer: CEO	C/O STERICYCLE INC., 28161 N KEITH DRIVE, LAKE FOREST IL 60045
Stephen C Hooley	director	2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
Hackney Jesse Joel Jr	director	2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
William J. Seward	officer: EVP, Chief Commercial Officer	28161 N. KEITH DRIVE, LAKE FOREST IL 60045
Richard Michael Moore	officer: EVP North America Operations	2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015